Prosight Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Prosight Management's BSX Position: Q3 2026 in Review
Prosight Management reduced its Boston Scientific (BSX) stake by 57% in Q3 2026, selling an estimated $33.3M and leaving 550,000 shares worth $24M. The position accounts for 4.66% of the portfolio, ranked #7.
Prosight Management first reported a position in BSX in Q3 2025 and has held it in 5 quarters since. The position peaked at $54.2M in Q2 2026. 1,512 funds tracked by Wall St. Rank hold BSX as of Q3 2026.
- Prosight Management held 550,000 shares of Boston Scientific worth $24M as of Q3 2026.
- Prosight Management sold 720,273 Boston Scientific shares in Q3 2026, an estimated $33.3M.
- Boston Scientific made up 4.66% of Prosight Management's portfolio in Q3 2026, its #7 holding.
- Prosight Management first reported a position in Boston Scientific in Q3 2025 and has held it in 5 quarters since.
- Prosight Management's Boston Scientific position peaked at $54.2M in Q2 2026.
- 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.
Based on Prosight Management's 13F filing for Q3 2026, filed 13 Nov 2026.